Michelle Doig

Michelle joined Omega Funds in 2016. She has nearly 20 years of experience advising life sciences companies on private placements, public equity financing and M&A transactions. Previously, Michelle worked as Director of Corporate Finance at Third Rock Ventures, where she supported numerous portfolio companies. Prior to joining Third Rock, Michelle was Principal, Corporate Finance, at Abingworth. She was also a life sciences investment banker with Lehman Brothers International in London, JP Morgan/H&Q in New York and Morgan Stanley in Toronto and New York. Michelle has executed more than 40 equity and convertible transactions and numerous IPOs, private placements and M&A transactions for companies, including Gilead, MedImmune, Millennium, Illumina and Sepracor. Michelle graduated with an Honor’s degree in Business Administration from the Richard Ivey School of Business at the University of Western Ontario in London.